#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA619928	B	In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells		68		cell-based format	Scientific Literature
2.	ALA740424	T	Acute lethal toxicity (peroral administration), determined by observing the mortality for 7 days after the administration in mouse	Mus musculus	28		organism-based format	Scientific Literature
3.	ALA760771	B	In vitro inhibition of Prostaglandin G/H synthase pathway in rat basophilic leukemia (RBL-1) cells		66		cell-based format	Scientific Literature
4.	ALA781065	F	Inhibitory effect for increase in plasma prostaglandin E2 (PGE2) level after arachidonic acid (AA) injection into COX-1 non-lipopolysaccharide-treated rats	Rattus norvegicus	2		organism-based format	Scientific Literature
5.	ALA779953	F	Dose required for 30% inhibition of adjuvant-induced arthritis	Rattus norvegicus	6		organism-based format	Scientific Literature
6.	ALA779954	F	Dose required for 30% inhibition of carrageenan-induced edema	Rattus norvegicus	6		organism-based format	Scientific Literature
7.	ALA779661	F	Inhibitory effect for increase in plasma prostaglandin E2 (PGE2) level after arachidonic acid (AA) injection into COX-2 lipopolysaccharide-treated rats	Rattus norvegicus	1		organism-based format	Scientific Literature
8.	ALA796120	F	Dose required for Ulcerogenic effect	Rattus norvegicus	5		organism-based format	Scientific Literature
9.	ALA804167	F	Lengths of bleeding ulcer of drug-administered group	Rattus norvegicus	5		organism-based format	Scientific Literature
10.	ALA799553	F	Antiinflammatory activity in the rat foot edema at the dose of 1-18 mg/kg po, the values in the parenthesis are 95% confidence.	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA872808	F	In vitro effect on production of lipopolysaccharide (LPS) -induced IL1-beta in human THP-1 cells	Homo sapiens	18		cell-based format	Scientific Literature
12.	ALA823624	F	Dose of the compound (oral administration) showing antiinflammatory effect on rat paw edema model (carrageenan-induced paw edema, CPE)	Rattus norvegicus	13		organism-based format	Scientific Literature
13.	ALA823626	F	Oral dose required for antiinflammatory effect on zymosan induced rat paw edema.	Rattus norvegicus	19		organism-based format	Scientific Literature
14.	ALA871818	F	Antiinflammatory effect (oral administration) on rat paw edema model (reversed passive Arthus reaction-induced paw edema) at 100 mg/kg	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA846763	F	In vitro effect on production of calcium ionophore (A23187) -induced Leukotriene B4 (LTB4) in rat peritoneal cells	Rattus norvegicus	19		organism-based format	Scientific Literature
16.	ALA848481	F	In vitro inhibitory effect on production of prostaglandin E2 (PGE2) in rat synovial cells.	Rattus norvegicus	31		cell-based format	Scientific Literature
17.	ALA1116254	A	Human intestinal absorption in po dosed human	Homo sapiens	201		organism-based format	Scientific Literature
18.	ALA1291825	B	Inhibition of COX-2 in rabbit peripheral venous blood assessed as formation of 12-hydroxyheptadecatrienoic acid after 24 hrs in by HPLC presence of calcium ionophore A23188 and lipopolysaccharide	Oryctolagus cuniculus	16		tissue-based format	Scientific Literature
19.	ALA1291826	B	Inhibition of COX-1 in rabbit peripheral venous blood assessed as formation of 12-hydroxyheptadecatrienoic acid after 24 hrs by HPLC in presence of calcium ionophore A23187	Oryctolagus cuniculus	16		single protein format	Scientific Literature
20.	ALA1291827	B	Inhibition of 5-LOX in rabbit peripheral venous blood assessed as formation of LBT4 after 30 mins by HPLC	Oryctolagus cuniculus	16		tissue-based format	Scientific Literature